News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial.
News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial. The findings were presented at Obesity 2011, the Obesity Society’s annual scientific meeting.
Researchers led by Judith Stern, ScD, professor at the University of California, Davis assigned 100 patients to 800 mg of Merastin or placebo for eight weeks. Subjects were instructed to walk five days a week and follow a standard 2000-calorie diet daily.
Compared to reductions in the placebo group, Merastin supplementation was associated with average reductions of 8.2 lbs in body weight, 2.3 inches in waist size, and 1.3 inches in hip size.
Merastin is a blend of Sphaeranthus indicus flower heads and mangosteen (Garcinia mangostana) fruit rind. Results of the trial were exhibited at last week’s SupplySide West show in Las Vegas.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.